30 closest matches · ranked by relevance
Electronic Medical Records
Primary: Change in Patient's Satisfaction, Change in Provider's Satisfaction (Mean/SD) — -0.033; 0.032; -0.018; 0.077 units on a scale — p=>0.05
Medication Adherence
Primary: Medication Specific Knowledge — 63.82; 62.80 score (0-100)
Hepatitis B
Primary: Serum Hepatitis B Surface Antigen Completion — 389; 177 Participants
Herpes Zoster Disease
Primary: Number of Participants Who Received the Herpes Zoster Vaccine — 500; 2089 Participants
Sexually Transmitted Diseases
Primary: Number of Patients Recording Preferences to Restrict Provider Access to Some or All Electronic Health Record (EHR) Data — 45; 13 participants
Colorectal Cancer · Breast Cancer · Coronary Heart Disease
Primary: Number of Subjects Who Discussed Disease Risk With Primary Care Provider — 905; 841 Participants
Diabetes Mellitus
Primary: Count of Participants Entering Flowsheet Data During Measurement Period, Extensive Margin — 4; 27; 44; 43 Participants
Disease
Primary: Number of Participants Using Evidence-based Template to Document Asthma Care Within an Electronic Medical Record — 41; 11 participants — p=.01
Electronic Health Records
Primary: Amount of Time to Complete Assessment and Plan — 8.5; 8.7 minutes — p=0.047
Patient Engagement · Medication Optimization · Heart Failure With Reduced Ejection Fraction
Primary: Percent of Participants Who Experienced an Initiation or Intensification of Their Guideline-Directed Medical Therapy (GDMT) — 29.7; 49.0 percentage of participants
Hypertension · Hyperlipidemia · Diabetes
Primary: Change in Composite Quality Score — 0.71; 0.70; 0.67; 0.70 score on a scale
Pulmonary Disease, Chronic Obstructive
Primary: Change From Baseline in Forced Expiratory Volume in One Second (FEV1) — -0.03; 0.07; -0.09; -0.08 Liter
Alcohol Use Disorder (AUD)
Primary: Percent of New Alcohol Use Disorder (AUD) Diagnosis Episodes That Meet Criteria for AUD Treatment Engagement Among Patients With a New AUD Diagnosis Who Are Empaneled to…
Hypertension
Primary: Systolic Blood Pressure — 134.5; 141.7; 134.6 mm Hg
Opioid Use, Unspecified
Primary: Safe Medication Dosing (Prescription Understanding) — 0.67; 0.83; 0.79 probability
Colon Cancer · Lung Cancer · Prostate Cancer
Primary: Differences in Time to Documented Follow-up of a Red Flag Suggestive of Cancer — 104; 200; 144; 192 Days — p=<0.05
Type 2 Diabetes
Primary: Prescription Understanding — 0.81; 0.82; 0.78 Probability
Diabetes Mellitus, Type 2 · Hypertension · Hyperlipidemia
Primary: Primary Effectiveness Outcome - LDL — 57.9; 54.8 percentage of time spent at goal
Obesity
Primary: Compliance Rate — 87; 76 percentage of participants
Tobacco Use Cessation · Tobacco Smoking
Primary: Number of Participants Referred — 1380; 331 Participants — p=<.0001
High-risk Medications
Primary: Medication Knowledge (0-100) — 71.2; 71.9; 73.2; 74.9 score on a scale
Medication Reconciliation
Primary: Number of Participants With Changes/Updates in Medication List — 101; 43 Participants — p=<0.0001
Diabetes
Primary: Number of Participants Who Are CW-Compliant and CW-Noncompliant — 412; 704; 1232; 1854 Participants
Patient Computer Dialog
Primary: Patient Post Medical History Assessment Questionnaire — 8.4; 8.3 units on a scale
Clinical Deterioration · Hospital Medicine · Monitoring, Physiologic
Primary: Overall Rate of Escalation — 12.3; 11.3 escalations per 1,000 patient bed days — p=< 0.001
Metastatic Cancer
Primary: Overall Survival — 42.0; 43.5 percentage of participants
Disabling Medical Events · Disabled · Depression
Primary: Change in Barthel Index Score — 28.48; 34.92 score on a scale — p=0.007
Myocardial Infarction · Heart Attack
Primary: Emergency Room Visits — 40; 33 Emergency Room Visits
Diabetes Mellitus, Type 2
Primary: Missing EMR (Electronic Medical Record) Characteristic: Smoking — 9.1; 7.6; 10.7; 7.9 Percentage of participants
Heart Failure · Systolic Heart Failure
Primary: Number of Heart Failure Participants Deceased at 24 Months — 43 Participants